Arena Pharmaceuticals, Inc. Loss Contingency, Receivable, Current
Arena Pharmaceuticals, Inc. had Loss Contingency, Receivable, Current of $12.03 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyReceivableCurrent · last filed 2020-02-27
- 2018-03-31: Loss Contingency, Receivable, Current $12.03M.
- 2017-12-31: Loss Contingency, Receivable, Current $12.03M.
- 2017-09-30: Loss Contingency, Receivable, Current $12.03M.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2018-03-31 | $12.03M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $12.03M 10-K · filed 2020-02-27 |
| 2017-09-30 | $12.03M 10-Q · filed 2018-05-09 |